Aveanna’s Heartways Program Earns CHAP Disease Program Certification for Heart Failure
Event summary
- Aveanna Healthcare’s Heartways program received CHAP Disease Program Certification for Heart Failure on February 11, 2026.
- CHAP certification validates Aveanna’s adherence to high standards in program structure, quality metrics, and patient self-management tools.
- Heartways aims to reduce hospitalizations and improve outcomes for heart disease patients through evidence-based care protocols.
- Heart disease affects 127.9 million U.S. adults, costing the healthcare system $422.3 billion annually.
The big picture
Aveanna’s certification underscores the growing emphasis on specialized disease management in home healthcare, aligning with broader industry trends toward value-based care. The recognition positions Aveanna as a leader in chronic disease management, particularly as heart disease remains a costly and prevalent health challenge. The certification could also set a precedent for other home healthcare providers seeking to differentiate through quality certifications.
What we're watching
- Program Scalability
- Whether Aveanna can sustain the Heartways program’s quality across its 15-state home health and hospice operations.
- Cost Efficiency
- How the program’s focus on reducing hospitalizations will impact Aveanna’s cost structure and hospital partner relationships.
- Regulatory Alignment
- The pace at which CHAP’s standards influence broader Medicare and Medicaid home healthcare regulations.
Our editorial coverage: